Preparation of functionally preserved CD4+ CD25high regulatory T cells from leukapheresis products from ulcerative colitis patients, applicable to regulatory T-cell transfer therapy

Author： Sumida Y.   Nakamura K.   Kanayama K.   Akiho H.   Teshima T.   Takayanagi R.  

Publisher： Ashgate Publishing Ltd

ISSN： 1465-3249

Source： Cytotherapy, Vol.10, Iss.7, 2008-01, pp. : 698-710

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Rapamycin enriches for CD4+ CD25+ CD27+ Foxp3+ regulatory T cells in ex vivo-expanded CD25-enriched products from healthy donors and patients with multiple sclerosis

By Keever-Taylor Ca   Browning Mb   Johnson Bd   Truitt Rl   Bredeson Cn   Behn B.   Tsao A.  

Cytotherapy, Vol. 9, Iss. 2, 2007-01 ,pp. : 144-157

Ashgate Publishing Ltd

Access to resources Recommend Favorite

CD4+ CD25+ regulatory T cells approach the clinic

By Edinger M.  

Cytotherapy, Vol. 10, Iss. 7, 2008-01 ,pp. : 655-656

Ashgate Publishing Ltd

Access to resources Recommend Favorite

Therapeutic potential of CD4 + CD25 + regulatory T cells in allogeneic transplantation

By Cohen JL   Salomon BL  

Cytotherapy, Vol. 7, Iss. 2, 2005-05 ,pp. : 166-170

Ashgate Publishing Ltd

Access to resources Recommend Favorite

CD4++ CD25++ regulatory T cells ameliorate Behcet's disease-like symptoms in a mouse model

By Shim Jua   Lee Eun-So   Park Sun   Bang Dongsik   Sohn Seonghyang  

Cytotherapy, Vol. 13, Iss. 7, 2011-08 ,pp. : 835-847

Ashgate Publishing Ltd

Access to resources Recommend Favorite

Selection of autologous CD4+ T-cells for adoptive T-cell substitution in patients with CD23+ B-cell CLL

By Dettke M   Berger R   Jurko S   Mitterbauer G   Schwarzmeier JD   Höcker P  

Cytotherapy, Vol. 4, Iss. 2, 2002-03 ,pp. : 119-125

Ashgate Publishing Ltd

Access to resources Recommend Favorite